Serum levels of infliximab and adalimumab are associated with deep remission in inflammatory bowel disease Óscar Pascual-Marmaneu; María D. Belles-Medall; Raúl Ferrando-Piqueres; Pedro Almela-Notari; María Mendoza-Aguilera; Tamara Álvarez-Martín;